Begoña Carreño
InvestorChief Business Development Officer at Aspeya at Invivo Capital Partners
Switzerland
About
Chief Business Development Officer at Aspeya (formerly Vectura Fertin Pharma) with over 20 years of pharmaceutical development experience, including 18 years in Business Development & Licensing at Novartis. She holds a Ph.D. in Drug Delivery and serves on boards including ProQR and the IRB Barcelona advisory board.
Colleagues at Invivo Capital Partners
Albert Ferrer
Partner at Invivo Capital Partners
Borja Ruiz
Investment Analyst at Invivo Capital Partners
Cinta Diez
Investment Analyst at Invivo Capital Partners
Gemma Guinart
Principal at Invivo Capital Partners
Josep M. Martorell
Partner at Invivo Capital Partners
Laura Rodríguez
Partner at Invivo Capital Partners
Luis Pareras
Managing Partner at Invivo Capital Partners
Luis Serrano
Director, CRG (Centre for Genomic Regulation) at Invivo Capital Partners
Frequently asked questions
- Who is Begoña Carreño?
- Chief Business Development Officer at Aspeya (formerly Vectura Fertin Pharma) with over 20 years of pharmaceutical development experience, including 18 years in Business Development & Licensing at Novartis. She holds a Ph.D. in Drug Delivery and serves on boards including ProQR and the IRB Barcelona advisory board.
- Where does Begoña Carreño work?
- Begoña Carreño is Chief Business Development Officer at Aspeya at Invivo Capital Partners.